Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Effective porous plastic filters for respiratory devices

Porvair Sciences reports on increased demand for the 3D molded intake filters and vent diffusers it supplies to GCE Healthcare - manufacturer of the Zen-O lite Portable Oxygen Concentrator.

From Porvair Sciences Limited 8 Apr 2020

Smokers need to quit during coronavirus pandemic

Smoking tobacco may aggravate the effects of coronavirus disease (COVID-19). Health experts are urging smokers to quit and cigarette companies to stop producing tobacco products to help alleviate the risks of COVID-19. A new study from China highlights the risk of smoking during the coronavirus pandemic.

7 Apr 2020

Lessons from Italy's COVID-19 pandemic underscore the need for more research

A new viewpoint article published in the journal JAMA Internal Medicine dissects different factors that contributed to the dire COVID-19 situation in Italy, emphasizing several aspects relevant to the international healthcare community.

7 Apr 2020

Vaping with counseling more effective than counseling alone for smoking cessation

Smokers who received smoking cessation counseling and used electronic cigarettes containing nicotine were more than twice as likely to successfully quit smoking compared to those who received counseling but did not use e-cigarettes, in a clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

COVID-19 and its effects on the cardiovascular system

Researcher have reviewed the evidence showing the effects of the SARS-CoV-2 or novel coronavirus infection (COVID-19) on the cardiovascular system. Their study titled, “Potential Effects of Coronaviruses on the Cardiovascular System: A Review,” was published in the latest issue of JAMA Cardiology.

29 Mar 2020

Three-drug combination reduces all-cause mortality in COPD patients

Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

18 Mar 2020

UK study highlights importance of breathing tests in the assessment of COPD

A UK study of patients participating in low-dose CT lung cancer screening highlights the importance of spirometry (breathing tests) in the assessment of possible chronic obstructive pulmonary disease (COPD), and demonstrates that over-reliance on radiological changes alone may result in detection of clinically insignificant disease.

13 Mar 2020

Study details first locally-transmitted case of severe SARS-CoV-2 in the USA

Person-to-person transmission of SARS-CoV-2 occurred between two people with prolonged, unprotected exposure while the first patient was symptomatic. Despite active monitoring and testing of 372 contacts of both cases, no further transmission was detected

12 Mar 2020

Lung cancer mortality could be reduced by including smoking cessation with screening

Including smoking cessation with existing lung cancer screening efforts would reduce lung cancer mortality by 14 percent and increase life-years gained by 81 percent compared with screening alone, according to a study from Rafael Meza from the University of Michigan and colleagues and published in the Journal of Thoracic Oncology, a publication of the International Association for the Study of Lung Cancer.

9 Mar 2020

Asthma and COPD can increase risk of rheumatoid arthritis

Asthma and chronic obstructive pulmonary disease (COPD) were each associated with increased risk for developing rheumatoid arthritis in a study published in Arthritis & Rheumatology.

4 Mar 2020

Health effects of the Australian bushfires

A viewpoint published in the journal JAMA internal Medicine February 28, 2020, discusses the lessons learned from the recent Australian bushfires in regards to climate change and public health.

2 Mar 2020

New inhalation therapy could relieve lung fibrosis in mice and rats

A new study published in the journal Nature Communications in February 2020 shows that secretions from stem cells in the lung can be utilized to nebulize injured lungs due to several types of lung fibrosis in rats and mice. This could well result in the development of less invasive and more effective therapies for lung fibrosis.

1 Mar 2020

Chronic cough could be eased with new drug

A pair of studies have shown that chronic cough and its distressing symptoms could be eased with the help of a new drug. Also, the drug does not have side effects that can restrict its use, explain the researchers. The results of the two studies are published in The Lancet Respiratory Medicine, and the European Respiratory Journal, respectively.

26 Feb 2020

Researchers develop novel therapy to combat antibiotic-resistant superbug infections

There may be a solution on the horizon to combating superbug infections resistant to antibiotics. The tenacious bacteria and fungi sicken more than 2.8 million people and lead to more than 35,000 deaths in the United States each year.

20 Feb 2020

Study finds higher and earlier incidence of COPD in people living with HIV

eople in Ontario living with HIV had a 34 per cent higher incidence rate of chronic obstructive pulmonary disease and were diagnosed with the disease about 12 years younger than HIV-negative individuals, according to a study led by researchers at St. Michael's Hospital of Unity Health Toronto and ICES.

18 Feb 2020

Sex-differences in airway anatomy develop during puberty, study reveals

Sex differences in airway size are not innate, but likely develop because of hormonal changes around puberty, reports a new study by the University of Waterloo.

14 Feb 2020

Titanium nanoparticles found in coal smog and ash can cause lung damage in mice

Virginia Tech scientists have discovered that incredibly small particles of an unusual and highly toxic titanium oxide found in coal smog and ash can cause lung damage in mice after a single exposure, with long-term damage occurring in just six weeks.

5 Feb 2020

In-home breathing device may offer hope for people with COPD

In a new paper published Feb. 4 in JAMA, Mayo Clinic researchers describe the benefits of in-home noninvasive ventilation therapy- which includes a type referred to as bilevel positive airway pressure, or BiPAP- for many patients with chronic obstructive pulmonary disease.

4 Feb 2020

ResMed and ATS Foundation award $100,000 to COPD digital health researcher

ResMed and ATS Foundation have awarded their third $100,000 Research Fellowship grant to Claude Farah, PhD, of the Woolcock Institute of Medical Research in Sydney, Australia, to study how remote monitoring can help improve the management of patients with chronic obstructive pulmonary disease, or COPD.

From ResMed Corp 4 Feb 2020

Fermented soy products may help you live longer

A new study has shown that products made of fermented soy such as miso and soy sauce can help individuals live longer. The study titled, “Association of soy and fermented soy product intake with total and cause specific mortality: prospective cohort study,” was published in the latest issue of the journal British Medical Journal.

2 Feb 2020